The Current Ratio as of November 2024 (TTM) for Timber Pharmaceuticals, Inc. (TMBR) is 0.50

According to Timber Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.50. This represents a change of -67.29% compared to the average of 1.52 of the last 4 quarters.

Timber Pharmaceuticals, Inc. (TMBR) Historical Current Ratio (quarterly & annually)

How has TMBR Current Ratio performed in the past?

The mean historical Current Ratio of Timber Pharmaceuticals, Inc. over the last ten years is 2.25. The current 0.50 Current Ratio has changed 2.10% with respect to the historical average. Over the past ten years (40 quarters), TMBR's Current Ratio was at its highest in in the June 2020 quarter at 10.47. The Current Ratio was at its lowest in in the March 2013 quarter at 0.

Timber Pharmaceuticals, Inc. (TMBR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Timber Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Timber Pharmaceuticals, Inc. (TMBR) Average Current Ratio

How has TMBR Current Ratio performed in the past?

The current Current Ratio of Timber Pharmaceuticals, Inc. (TMBR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Timber Pharmaceuticals, Inc. (TMBR) Current Ratio vs. Peers

How is TMBR’s Current Ratio compared to its peers?

Timber Pharmaceuticals, Inc.’s Current Ratio is less than Salarius Pharmaceuticals, Inc. (2.98), less than Artelo Biosciences, Inc. (14.58), less than Nutriband Inc. (6.57), less than Aileron Therapeutics, Inc. (4.69), less than Artelo Biosciences, Inc. (14.58), less than Histogen Inc. (4.05), less than Curis, Inc. (1.78), less than First Wave BioPharma, Inc. (1.21), less than SAB Biotherapeutics, Inc. (5.24), greater than Vaccinex, Inc. (0.42), less than GeoVax Labs, Inc. (0.60), less than TRACON Pharmaceuticals, Inc. (0.66), less than Entera Bio Ltd. (7.41), less than Tempest Therapeutics, Inc. (2.17), less than Better Therapeutics, Inc. (0.57), less than Neoleukin Therapeutics, Inc. (15.33), less than Senti Biosciences, Inc. (4.89), less than Hillstream BioPharma, Inc. (2.25), less than Quoin Pharmaceuticals, Ltd. (3.35),

Build a custom stock screener for Timber Pharmaceuticals, Inc. (TMBR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Timber Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Timber Pharmaceuticals, Inc. (TMBR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Timber Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.